ABAX Abaxis, Inc. (delisted)

Abaxis to Present at the SunTrust Robinson Humphrey's 34th Annual Institutional Investor Conference UNION CITY, Calif., April 5 /PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, Chief Executive Officer, will present at the SunTrust Robinson Humphrey's 34th Annual Institutional Investor Conference on Monday, April 11, 2005 at 4:00 p.m. Eastern at the Ritz-Carlton Buckhead in Atlanta, Georgia. Interested investors are invited to listen to a live audio Web cast of the company's presentation by logging onto http://www.wsw.com/webcast/strh13/abax/. Replays will be available starting approximately ten minutes after the initial presentation and will remain accessible for 30 days. About Abaxis ABAXIS develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 6.9 kilogram, portable analyzer and a series of 8-cm diameter single-use plastic disks, called rotors or reagent discs that contain all the reagents necessary to perform a fixed menu of tests. The system can be operated with minimal training and perform multiple tests on whole blood using either venous or fingerstick samples. The system provides test results in less than 14 minutes with the precision and accuracy equivalent to a clinical laboratory. For more information please contact: Clint Severson Chief Executive Officer ABAXIS, Inc. 510-675-6500 RCG Capital Markets Group Joe Dorame, Joe Diaz, Robert Blum 480-675-0400 DATASOURCE: Abaxis, Inc. CONTACT: Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Joe Dorame or Joe Diaz or Robert Blum, all of RCG Capital Markets Group, +1-480-675-0400, for ABAXIS, Inc. Web site: http://www.wsw.com/webcast/strh13/abax

Copyright